Content about Antidepressants

May 21, 2013
Vitamin C kills drug-resistant TB, researchers find

Vitamin C can kill a virulent form of tuberculosis, researchers in New York have found.

NEW YORK — Vitamin C can kill a virulent form of tuberculosis, researchers in New York have found.

The researchers, at Yeshiva University's Albert Einstein College of Medicine, determined that vitamin C was able to kill drug-resistant forms of the bacteria that causes tuberculosis in lab culture, publishing their findings in the online journal Nature Communications. They had been looking into how TB bacteria become resistant to isoniazid, a first-line drug used to treat it.

January 29, 2013
Citizen's Petition asks that behind-the-counter status be mandated for St. John's Wort

Pharmacists Planning Services, Inc. earlier this month filed a Citizen's Petition with the Food and Drug Administration calling to move St. John's Wort, a mood enhancing supplement, behind the counter.

SAN RAFAEL, Calif. — Pharmacists Planning Services, Inc. earlier this month filed a Citizen's Petition with the Food and Drug Administration calling to move St. John's Wort, a mood enhancing supplement, behind the counter. 

November 27, 2012
Wockhardt receives three FDA approvals

Indian generic drug maker Wockhardt received three new drug approvals from the Food and Drug Administration, agency records show.

SILVER SPRING, Md. — Indian generic drug maker Wockhardt received three new drug approvals from the Food and Drug Administration, agency records show.

September 4, 2012
FDA approves Wockhardt antidepressant

The Food and Drug Administration has approved a generic antidepressant made by Wockhardt, the Indian drug maker said Tuesday.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a generic antidepressant made by Wockhardt, the Indian drug maker said Tuesday.

Wockhardt announced the FDA approval of its bupropion hydrochloride extended-release tablets in the 100 mg, 150 mg and 200 mg strengths.

The drug is a generic version of GlaxoSmithKline's Wellbutrin SR, various versions of which have a market of about $268 million, according to IMS Health.

March 1, 2011
Express Scripts finds generic antidepressant users as adherent as brand-name counterparts

Patients who take generic antidepressants will remain as adherent as those who take brand-name drugs to treat the condition, according to a new study.

ST. LOUIS — Patients who take generic antidepressants will remain as adherent as those who take brand-name drugs to treat the condition, according to a new study.

The study, conducted by Express Scripts and published in the Journal of Managed Care Pharmacy, found patients starting generic selective serotonin reuptake inhibitors and generic selective norepinephrine reuptake inhibitors had a discontinuation rate of 44.2%, compared with 46.8% among those on brand-name SSRIs and SNRIs.

December 17, 2010
Study: Drug interactions may be imminent among antidepressant users

Many older Americans prescribed antidepressants may be taking medication that could adversely interact with the antidepressant, a new study found.

ANN ARBOR, Mich. — Many older Americans prescribed antidepressants may be taking medication that could adversely interact with the antidepressant, a new study found.

September 30, 2010
Mylan's generic Wellbutrin XL enters market

Mylan has launched a generic version of a common antidepressant, the company said Friday....

PITTSBURGH Mylan has launched a generic version of a common antidepressant, the company said Friday.

 

Mylan announced the launch of bupropion hydrochloride extended-release tablets in the 150-mg and 300-mg strengths, a once-daily treatment for depression.

 

 

The drug is a generic version of GlaxoSmithKline’s Wellbutrin XL. Various versions of the drug had sales of around $752 million during the 12-month period ended in June, according to IMS Health.

 

August 9, 2010
Angelini Labopharm launches Oleptro

Drug maker Angelini Labopharm has launched a new treatment for depression....

July 20, 2010
Caraco launches generic Wellbutrin SR

Generic drug maker Caraco Pharmaceutical Labs has launched a generic antidepressant, Caraco said Wednesday....

DETROIT Generic drug maker Caraco Pharmaceutical Labs has launched a generic antidepressant, Caraco said Wednesday.

 

The drug maker announced the launch of bupropion hydrochloride extended-release tablets in the 150 mg and 200 mg strengths.

 

 

The drug is a generic version of GlaxoSmithKline’s Wellbutrin SR. Various versions of the drug have annual sales of $300 million, according to Caraco.

 

July 20, 2010
FDA approves additional strengths of Actavis' generic Wellbutrin SR

Actavis has received regulatory approval from the Food and Drug Administration for a generic antidepressant,...

MORRISTOWN, N.J. Actavis has received regulatory approval from the Food and Drug Administration for a generic antidepressant, the drug maker announced Wednesday.

Actavis said it immediately will begin distributing its bupropion HCl extended-release (SR) tablets in 100-mg and 200-mg strengths. The drug is the generic equivalent of GlaxoSmithKline's Wellbutrin SR. Actavis already has marketed generic Wellbutrin SR in the 150-mg strength. The drug maker received approval in March 2008.

February 3, 2010
Labopharm's Oleptro approved by FDA

The Food and Drug Administration has approved a new drug for treating major depressive disorder...